108 related articles for article (PubMed ID: 21824113)
1. Expression of hepatocyte growth factor in the skin of amyotrophic lateral sclerosis.
Nomura M; Oketa Y; Yasui K; Ishikawa H; Ono S
Acta Neurol Scand; 2012 Jun; 125(6):389-97. PubMed ID: 21824113
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis.
Suzuki M; Watanabe T; Mikami H; Nomura M; Yamazaki T; Irie T; Ishikawa H; Yasui K; Ono S
J Neurol Sci; 2009 Oct; 285(1-2):125-9. PubMed ID: 19592043
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of ubiquitin in the skin of sporadic amyotrophic lateral sclerosis.
Watanabe T; Okeda Y; Yamano T; Ono S
J Neurol Sci; 2010 Nov; 298(1-2):52-6. PubMed ID: 20850799
[TBL] [Abstract][Full Text] [Related]
4. Increased progranulin in the skin of amyotrophic lateral sclerosis: an immunohistochemical study.
Yasui K; Oketa Y; Higashida K; Fukazawa H; Ono S
J Neurol Sci; 2011 Oct; 309(1-2):110-4. PubMed ID: 21802097
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of valosin-containing protein in the skin of patients with amyotrophic lateral sclerosis.
Ishikawa H; Yasui K; Oketa Y; Suzuki M; Ono S
J Clin Neurosci; 2012 Apr; 19(4):522-6. PubMed ID: 22321369
[TBL] [Abstract][Full Text] [Related]
6. Abundant FUS-immunoreactive pathology in the skin of sporadic amyotrophic lateral sclerosis.
Oketa Y; Higashida K; Fukasawa H; Tsukie T; Ono S
Acta Neurol Scand; 2013 Oct; 128(4):257-64. PubMed ID: 23448665
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of increased tumor necrosis factor-α in the skin of patients with amyotrophic lateral sclerosis.
Fukazawa H; Tsukie T; Higashida K; Fujikura M; Ono S
J Clin Neurosci; 2013 Oct; 20(10):1371-6. PubMed ID: 23850047
[TBL] [Abstract][Full Text] [Related]
8. Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation.
Kato S; Funakoshi H; Nakamura T; Kato M; Nakano I; Hirano A; Ohama E
Acta Neuropathol; 2003 Aug; 106(2):112-20. PubMed ID: 12707786
[TBL] [Abstract][Full Text] [Related]
9. Amyotrophic lateral sclerosis: evidence for intact hepatocyte growth factor/met signalling axis.
Kern MA; Friese M; Grundstrom E; Korhonen L; Wallin A; Aquilonius SM; Askmark H; Schirmacher P; Lindholm D
Cytokine; 2001 Sep; 15(6):315-9. PubMed ID: 11594798
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical studies of angiogenin in the skin of patients with amyotrophic lateral sclerosis.
Higashida K; Tsukie T; Fukazawa H; Fujikura M; Ono S
J Neurol Sci; 2013 Mar; 326(1-2):18-23. PubMed ID: 23351638
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosis.
Ono S; Hu J; Imai T; Shimizu N; Tsumura M; Nakagawa H
J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):199-203. PubMed ID: 10896693
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis.
Suzuki M; Mikami H; Watanabe T; Yamano T; Yamazaki T; Nomura M; Yasui K; Ishikawa H; Ono S
Acta Neurol Scand; 2010 Nov; 122(5):367-72. PubMed ID: 20175762
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
[TBL] [Abstract][Full Text] [Related]
14. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).
Fang L; Huber-Abel F; Teuchert M; Hendrich C; Dorst J; Schattauer D; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Tumani H; Ludolph AC; Brettschneider J
J Neurol Sci; 2009 Oct; 285(1-2):62-6. PubMed ID: 19523650
[TBL] [Abstract][Full Text] [Related]
15. [ALS and neurotrophic factors--HGF as a novel neurotrophic and neuroregenerative factor].
Funakoshi H; Ohya W; Kadoyama K; Nakamura T
Brain Nerve; 2007 Oct; 59(10):1195-202. PubMed ID: 17969361
[TBL] [Abstract][Full Text] [Related]
16. [Skin changes in amyotrophic lateral sclerosis].
Ono S
Brain Nerve; 2007 Oct; 59(10):1099-107. PubMed ID: 17969350
[TBL] [Abstract][Full Text] [Related]
17. Increased cystatin C immunoreactivity in the skin in amyotrophic lateral sclerosis.
Ono S; Shimizu N; Imai T; Mihori A; Nagao K
Acta Neurol Scand; 2000 Jul; 102(1):47-52. PubMed ID: 10893063
[TBL] [Abstract][Full Text] [Related]
18. [Hepatocyte growth factor therapy for amyotrophic lateral sclerosis].
Aoki M
Brain Nerve; 2012 Mar; 64(3):245-54. PubMed ID: 22402718
[TBL] [Abstract][Full Text] [Related]
19. Persistent cleavage and nuclear translocation of apoptosis-inducing factor in motor neurons in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Sasaki S; Yamamoto T; Kobayashi M
Acta Neuropathol; 2009 Dec; 118(6):755-62. PubMed ID: 19669652
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
